Interleukin-2 as anticancer immunotherapy in the age of checkpoint inhibition

被引：1
|
作者：
Garbe, Claus [1 ]
机构：
[1] Eberhard Karls Univ Tubingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
D O I：
10.21037/tcr.2016.07.02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S313 / S314
页数：2
相关论文
共 50 条
  • [1] Liposomal delivery of interleukin-2 in locoregional anticancer immunotherapy
    Storm, G
    Koppenhagen, FJ
    Steerenberg, PA
    denOtter, W
    Crommelin, DJA
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 95 - 96
  • [2] INTERLEUKIN-2 IN ANTICANCER THERAPY
    HERRERA, A
    PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 1075 - 1076
  • [3] INTERLEUKIN-2 AS AN ANTICANCER AGENT
    HELLMANN, K
    BRITISH MEDICAL JOURNAL, 1988, 297 (6662): : 1493 - 1493
  • [4] INTERLEUKIN-2 - SUNRISE FOR IMMUNOTHERAPY
    不详
    LANCET, 1989, 1 (8633): : 308 - 308
  • [5] DELIVERY OF INTERLEUKIN-2 FOR IMMUNOTHERAPY
    KAPLAN, DR
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 662 (02): : 315 - 323
  • [6] INTERLEUKIN-2 IMMUNOTHERAPY IN CHILDREN
    CHIEN, CH
    HSIEH, KH
    PEDIATRICS, 1990, 86 (06) : 937 - 943
  • [7] RATIONAL IMMUNOTHERAPY WITH INTERLEUKIN-2
    KAPLAN, G
    COHN, ZA
    SMITH, KA
    BIO-TECHNOLOGY, 1992, 10 (02): : 157 - 162
  • [8] CORTICOSTEROID INTERLEUKIN-2 INTERACTIONS - INHIBITION OF BINDING OF INTERLEUKIN-2 TO INTERLEUKIN-2 RECEPTORS
    HORST, HJ
    FLAD, HD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1987, 68 (01): : 156 - 161
  • [9] LOWEST DOSE INTERLEUKIN-2 IMMUNOTHERAPY
    SMITH, KA
    BLOOD, 1993, 81 (06) : 1414 - 1423
  • [10] IMMUNOTHERAPY WITH INTERLEUKIN-2 AND SKIN CHANGES
    LARBRE, B
    NICOLAS, JF
    SARRET, Y
    TOGNET, E
    MERCATELLO, A
    THIVOLET, J
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1993, 120 (08): : 528 - 533
12345